These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1070 related items for PubMed ID: 1371965

  • 21. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
    Rottem M, Hull G, Metcalfe DD.
    Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
    [Abstract] [Full Text] [Related]

  • 22. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
    Misago M, Chiba S, Kikuchi M, Tsukada J, Sato T, Oda S, Eto S.
    Int J Cell Cloning; 1989 Jan; 7(1):39-49. PubMed ID: 2465360
    [Abstract] [Full Text] [Related]

  • 23. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.
    McNiece IK, Langley KE, Zsebo KM.
    Exp Hematol; 1991 Mar; 19(3):226-31. PubMed ID: 1704845
    [Abstract] [Full Text] [Related]

  • 24. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A, Piaggio G, Podestá M, Raffo MR, Tedone E, Sogno G, Benvenuto F, Figari O, Grassia L, Bagnara GP.
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [Abstract] [Full Text] [Related]

  • 25. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N, Koike K, Ito S, Okumura N, Kamijo T, Shiohara M, Amano Y, Tsuji K, Nakahata T, Oda M.
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [Abstract] [Full Text] [Related]

  • 26. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Interleukin-6 is a survival factor for committed myeloid progenitor cells.
    Kerst JM, Slaper-Cortenbach IC, van der Schoot CE, Hooibrink B, von dem Borne AE, van Oers RH.
    Exp Hematol; 1993 Nov; 21(12):1550-7. PubMed ID: 7691639
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Direct synergistic effects of IL-4 and IL-11 on proliferation of primitive hematopoietic progenitor cells.
    Jacobsen FW, Keller JR, Ruscetti FW, Veiby OP, Jacobsen SE.
    Exp Hematol; 1995 Aug; 23(9):990-5. PubMed ID: 7543420
    [Abstract] [Full Text] [Related]

  • 31. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L, Heimfeld S, Broxmeyer HE.
    Blood Cells; 1994 Aug; 20(2-3):436-54. PubMed ID: 7538350
    [Abstract] [Full Text] [Related]

  • 32. Functional characterization of mouse granulocytes and macrophages produced in vitro from bone marrow progenitors stimulated with interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Bender JG, Unverzagt KL, Maples PB, Mehrotra Y, Mellon J, Van Epps DE, Stewart CC.
    Exp Hematol; 1992 Oct; 20(9):1135-40. PubMed ID: 1361455
    [Abstract] [Full Text] [Related]

  • 33. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD.
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [Abstract] [Full Text] [Related]

  • 34. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow.
    van de Ven C, Ishizawa L, Law P, Cairo MS.
    Exp Hematol; 1995 Nov; 23(12):1289-95. PubMed ID: 7589284
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Histamine-producing cell-stimulating activity. A biological activity shared by interleukin 3 and granulocyte-macrophage colony-stimulating factor.
    Dy M, Schneider E, Gastinel LN, Auffray C, Mermod JJ, Hamburger J.
    Eur J Immunol; 1987 Sep; 17(9):1243-8. PubMed ID: 2888659
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Upregulation of HLA class II, but not intercellular adhesion molecule 1 (ICAM-1) by granulocyte-macrophage colony stimulating factor (GM-CSF) or interleukin-3 (IL-3) in synergy with dexamethasone.
    Sadeghi R, Feldmann M, Hawrylowicz C.
    Eur Cytokine Netw; 1992 Sep; 3(4):373-80. PubMed ID: 1358241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.